SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer
Clinical trial NCT03443492 · COMPLETED
Trial details
- NCT number
- NCT03443492
- Sponsor
- National Health Research Institutes, Taiwan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2019-11-30
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.